scholarly journals Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance

10.2741/3243 ◽  
2009 ◽  
Vol Volume (14) ◽  
pp. 237 ◽  
Author(s):  
Konstantinos Tziomalos
2004 ◽  
Vol 77 (11) ◽  
pp. 1683-1692 ◽  
Author(s):  
Kai Sun ◽  
Eva Kiss ◽  
Jens Bedke ◽  
Tomislav Stojanovic ◽  
Yanhua Li ◽  
...  

2014 ◽  
Vol 56 (2) ◽  
pp. 111-124 ◽  
Author(s):  
Ali Kermanizadeh ◽  
Caroline Chauché ◽  
David M. Brown ◽  
Steffen Loft ◽  
Peter Møller

1981 ◽  
Vol 200 (3) ◽  
pp. 597-603 ◽  
Author(s):  
Z W Kamiński ◽  
M M Jezewska

The course of the reaction sequence hypoxanthine leads to xanthine leads to uric acid, catalysed by the NAD+-dependent activity of xanthine oxidoreductase, was investigated under conditions either of immediate oxidation of the NADH formed or of NADH accumulation. The enzymic preparation was obtained from rat liver, and purified 75-fold (as compared with the 25000 g supernatant) on a 5′-AMP-Sepharose 4B column; in this preparation the NAD+-dependent activity accounted for 100% of total xanthine oxidoreductase activity. A spectrophotometric method was developed for continuous measurements of changes in the concentrations of the three purines involved. The time course as well as the effects of the concentrations of enzyme and of hypoxanthine were examined. NADH produced by the enzyme lowered its activity by 50%, resulting in xanthine accumulation and in decreases of uric acid formation and of hypoxanthine utilization. The inhibition of the Xanthine oxidoreductase NAD+-dependent activity by NADH is discussed as a possible factor in the regulation of IMP biosynthesis by the ‘de novo’ pathway or (from unchanged hypoxanthine) by ther salvage pathway.


2020 ◽  
Vol 160 ◽  
pp. 149-162 ◽  
Author(s):  
Geir Bjørklund ◽  
Alexey A. Tinkov ◽  
Božena Hosnedlová ◽  
Rene Kizek ◽  
Olga P. Ajsuvakova ◽  
...  

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 604-P
Author(s):  
AKIFUMI KUSHIYAMA ◽  
TAKAKO KIKUCHI ◽  
HIROKI YAMAZAKI ◽  
TAKESHI YAMAMOTOYA ◽  
HIDEYUKI SAKODA ◽  
...  

Redox Biology ◽  
2017 ◽  
Vol 13 ◽  
pp. 163-169 ◽  
Author(s):  
Zhengbing Zhuge ◽  
Luciano L. Paulo ◽  
Arghavan Jahandideh ◽  
Maria C.R. Brandão ◽  
Petrônio F. Athayde-Filho ◽  
...  

Author(s):  
Kiranmai Mandava ◽  
Uma Rajeswari Batchu

<p>Xanthine oxidoreductase (XOR) is a widely distributed housekeeping enzyme in mammals that catalyzes the last two steps in human purine catabolism to produce uric acid. The enzyme exists as a homodimer with independent electron transfer in each monomer. This has been studied extensively as a major constituent of the milk fat globule membrane (MFGM) which surrounds fat globules in cow's milk even though purine catabolism is the most accepted function of XOR. A huge number of literature highlights on the different catalytic forms of XOR and their importance in the generation of reactive oxygen species/reactive nitrogen species (ROS/RNS) and synthesis of uric acid which are involved in many physiological and pathological processes. However, a slight ambiguity resides in their biochemical functions. The aim of this article was to review the literature published on the structural, catalytical, physiological and pathological role of XOR and to resolve the ambiguity in biochemical processes and to firm up various natural inhibitors of XOR collectively. Uric acid, the product of purine catabolism shows antioxidant activity, and XOR-derived ROS and RNS play a role in innate immunity, milk secretion and also be involved in signaling and metabolism of xenobiotics. Furthermore, XOR is likely to be engaged in pathology because of excessive production of uric acid and ROS/RNS. This review also reports natural XOR inhibitors in plants which inhibit the enzyme to treat XOR associated pathology.</p>


Sign in / Sign up

Export Citation Format

Share Document